<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">IRON SUCROSE INJECTION</span><br/>(i'ron su'crose)<br/><span class="topboxtradename">Venofer<br/></span><b>Classifications:</b> <span class="classification">blood formers, coagulators, and anticoagulants</span>; <span class="classification">iron preparation</span><br/><b>Prototype: </b>Ferrous Sulfate<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg elemental iron/5 mL vial</p>
<h1><a name="action">Actions</a></h1>
<p>A complex of polynuclear iron (III) hydroxide in sucrose. It is dissociated by the reticuloendothelial system (RES) into iron
         and sucrose.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Hemodialysis patients on erythropoietin therapy showed significant increases in serum iron and serum ferritin after 4 weeks
         of treatment with Venofer.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of iron deficiency anemia in patients with chronic renal failure (with or without concurrent administration of erythropoietin).</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Patients with iron overload, hypersensitivity to Venofer, or for anemia not caused by iron deficiency; concomitant use with
         an oral iron preparation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Patients with a history of hypotension; pregnancy (category B), lactation; older adults, decreased renal, hepatic, or cardiac
         function. Safety and effectiveness in children are not established.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Iron Deficiency Anemia</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 1 mL (20 mg) injected in dialysis line at rate of 1 mL/min up to 5 mL (100 mg) or infuse 100 mg in NS over 15 min 13
               times/wk<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> Give undiluted.  <span class="methodtype">IV Infusion:</span> Dilute one vial (100 mg) in a maximum of 100 mL NS immediately prior to infusion.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype"> Direct:</span> Give undiluted by IV push at a rate of 1 mL (20 mg) per min during dialysis. Do not exceed one vial (100 mg) per injection.
                  Avoid rapid injection.  <span class="methodtype">IV Infusion:</span> Infusion diluted solution into dialysis line at a rate of 100 mg over at least 15 min. Avoid rapid infusion.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> Do not mix with other medications or parenteral nutrition solutions. 
               </p>
</td>
</tr>
</table>
<ul>
<li>Store unopened vials preferably at 25° C (77° F), but room temperature permitted. Discard unused portion in opened
            vial.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Fever, pain, asthenia, malaise, <u>anaphylactoid reactions</u>. <span class="typehead">Cardiovascular:</span>
<span class="speceff-common">Hypotension,</span> chest pain, hypertension, hypervolemia. <span class="typehead">Digestive:</span> Nausea, vomiting, diarrhea, abdominal pain, elevated liver function tests. <span class="typehead">Musculoskeletal:</span>
<span class="speceff-common">Leg cramps,</span> muscle pain. <span class="typehead">CNS:</span> Headache, dizziness. <span class="typehead">Respiratory:</span> Dyspnea, pneumonia, cough. <span class="typehead">Skin:</span> Pruritus, injection site reaction. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May reduce absorption of <span class="classification">oral iron preparations</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Peak:</span> 4 wk. <span class="typehead">Distribution:</span> Primarily to blood with some distribution to liver, spleen, bone marrow. <span class="typehead">Metabolism:</span> Dissociated to iron and sucrose in reticuloendothelial system. <span class="typehead">Elimination:</span> Sucrose is eliminated in urine, 5% of iron excreted in urine. <span class="typehead">Half-Life:</span> 6 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Withhold drug and notify physician when serum ferritin level equals or exceeds established guidelines.</li>
<li>Stop infusion and notify physician for S&amp;S overdosage or infusing too rapidly: hypotension, edema; headache, dizziness, nausea,
            vomiting, abdominal pain, joint or muscle pain, and paresthesia.
         </li>
<li>Lab tests: Periodic serum ferritin, transferrin saturation, Hct, and Hgb.</li>
<li>Monitor patient carefully during the first 30 min after initiation of IV therapy for signs of hypersensitivity and anaphylactoid
            reaction (see Appendix F).
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report any of the following promptly: Itching, rash, chest pain, headache, dizziness, nausea, vomiting, abdominal pain, joint
            or muscle pain, and numbness and tingling.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>